ScholarIQanswers from OpenAlex

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study

PaperCitations, authors & open-access status

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study have?

ScholarIQcitation count

When was Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study published?

ScholarIQyear

Open the OpenAlex record →

What is the open-access status of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study?

ScholarIQoa status

Open the OpenAlex record →

What is the DOI of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study?

ScholarIQdoi

The DOI for Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study is on the source record.

Open the DOI →

What is the PMID of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study?

ScholarIQpmid

The PMID for Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study is on the source record.

Open the PMID →

What is the OpenAlex record for Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study?

ScholarIQopenalex

The OpenAlex for Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, in-vitro , in silico , and in-vivo study is on the source record.

Open the OpenAlex →

Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study

How many citations does Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study have?

When was Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study published?

What is the open-access status of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study?

What is the DOI of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study?

What is the PMID of Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study?

What is the OpenAlex record for Development of canagliflozin nanocrystals sublingual tablets in the presence of sodium caprate permeability enhancer: formulation optimization, characterization, <i>in-vitro</i> , <i>in silico</i> , and <i>in-vivo</i> study?

Related on ScholarIQ